(105 days)
Not Found
No
The summary describes a standard urodynamics testing system with data storage and reporting capabilities. There is no mention of AI, ML, or any related technologies in the intended use, device description, or performance studies. The clinical data section refers to published literature on the measurement technique, not on the performance of an AI/ML algorithm.
No.
The device is used for diagnostic testing and assessment of bladder activity, not for treatment or therapy.
Yes
The device performs "urodynamic testing" including "uroflowmeter, cystometry, micturition, electromyography and urethral pressure profiles" to assess "bladder activity" and "interrupt urine flow," which are all diagnostic procedures used to identify the cause of urinary problems.
No
The device description explicitly states the system combines a touchscreen PC with a console, includes a scale and a pump, and mentions hardware verification and validation in the performance studies. This indicates it is a hardware system with accompanying software, not a software-only device.
Based on the provided information, the CT3000Pro is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- CT3000Pro Function: The CT3000Pro performs urodynamic testing, which involves measuring physiological parameters related to the function of the bladder and urethra. While it does involve the collection of urine (for uroflow), the primary function is the measurement of physical properties and pressures within the urinary system, not the analysis of the chemical or biological composition of a specimen in vitro.
- Intended Use: The intended use describes the device as performing standard urodynamic tests and assessing pressure necessary to interrupt urine flow. This is a functional assessment of the urinary system in vivo, not an in vitro analysis of a specimen.
- Device Description: The description highlights components like a scale for urine flow, a pump for cystometrogram and urethral pressure profile studies, and software for running different types of urodynamic tests. These are all related to measuring physiological function, not analyzing specimens.
In summary, the CT3000Pro is a device used for in vivo physiological measurements of the urinary system, not for the in vitro analysis of specimens. Therefore, it does not fit the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The CT3000Pro is intended for urodynamic testing. The equipment performs standard tests including uroflowmeter, cystometry, micturition, electromyography and urethral pressure profiles. The non-invasive option utilizes a penile cuff (UroCuff-Classic or UroCuff-DC) for non-invasive testing of bladder activity, by assessing the pressure necessary to interrupt urine flow.
The CT3000Pro is intended for use under the direction of a licensed physician or health care professional in an office or hospital setting.
Product codes
FEN, EXQ
Device Description
The CT3000Pro system is an urodynamics testing system which combines an all-in-one touchscreen PC with the CT3000Pro console. Patient information and all data from the tests are stored on the PC's hard disk and the printer enables the user to print a hard copy report of the recorded data. It features a scale to record urine flow, as well as a pump for cystometrogram and urethral pressure profile studies.
The CT3000Pro PC software runs three types of tests: (a) catheterized urodynamics, (b) non-invasive urodynamics, and (c) uroflow studies. A brief overview of the three test procedures is given below:
- a. For catheterized urodynamics studies, the device has up to three pressure channels which record pressure from one or two catheters (Vesical and optionally Abdominal). Perianal surface electromyography (EMG) can be recorded. The CT3000Pro also has a remote control and an electronic leak point detector for recording events.
- b. For non-invasive urodynamics studies, the device utilizes a non-invasive UroCuff to apply pressure to the urine stream to determine the pressure required to interrupt the urine flow during a voiding pressure study. Perianal and/or Abdominal surface EMG can be recorded.
- c. For uroflow studies, the device utilizes the urine scale, which is used on voiding pressure studies as well.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
The CT3000Pro is intended for use under the direction of a licensed physician or health care professional in an office or hospital setting.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Clinical performance of the non-invasive uroflow measurement technique is demonstrated through clinical data from published literature. The use of UroCuff for non-invasive urodynamic studies has been evaluated by independent research teams and published in peer-reviewed literature. There have been 28 Original Research Articles published on UroCuff, as well as an additional 44 Original Research Abstracts, and 20 Technology Assessments, Clinical Guidelines and Review Articles. Specifically, a study on the use of UroCuff-Classic and UroCuff-DC using the CT3000Pro (and its predecessor CT3000Plus) supporting the safety and effectiveness was published in the Journal of Urology. This publication reports on the clinical experiences on over 50,000 UroCuff patients from 103 US hospitals and urology offices. The publication's authors practice at Mayo Clinic, Mount Sinai Hospital, and Chesapeake Urology. Each of these institutions utilizes UroCuff. From the literature data it was established that the effectiveness and safety profile of the subject device are acceptable.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.1620 Urodynamics measurement system.
(a)
Identification. A urodynamics measurement system is a device used to measure volume and pressure in the urinary bladder when it is filled through a catheter with carbon dioxide or water. The device controls the supply of carbon dioxide or water and may also record the electrical activity of the muscles associated with urination. The device system may include transducers, electronic signal conditioning and display equipment, a catheter withdrawal device to enable a urethral pressure profile to be obtained, and special catheters for urethral profilometry and electrodes for electromyography. This generic type of device includes the cystometric gas (carbon dioxide) device, the cystometric hydrualic device, and the electrical recording cystometer, but excludes any device that uses air to fill the bladder.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the seal of the Department of Health & Human Services. To the right of that is the FDA logo in blue, with the words "U.S. FOOD & DRUG" stacked on top of the word "ADMINISTRATION".
December 21, 2021
SRS Medical Lee Brody CEO 76 Treble Cove Road, Building #3 North Billerica, MA 01862
Re: K212830
Trade/Device Name: CT3000Pro Regulation Number: 21 CFR§ 876.1620 Regulation Name: Urodynamics Measurement System Regulatory Class: II Product Code: FEN, EXQ Dated: November 22, 2021 Received: November 23, 2021
Dear Lee Brody:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
1
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jessica K. Nguyen, Ph.D. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
2
Indications for Use
510(k) Number (if known) K212830
Device Name CT3000Pro
Indications for Use (Describe)
The CT3000Pro is intended for urodynamic testing. The equipment performs standard tests including uroflowmeter, cystometry, micturition, electromyography and urethral pressure profiles. The non-invasive option utilizes a penile cuff (UroCuff-Classic or UroCuff-DC) for non-invasive testing of bladder activity, by assessing the pressure necessary to interrupt urine flow.
The CT3000Pro is intended for use under the direction of a licensed physician or health care professional in an office or hospital setting.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for SRS Medical. The logo is in a light blue color. The text "SRS Medical" is in a sans-serif font. Below the text "SRS Medical" is the text "Driven by bladder function" in a smaller font.
510(k) Summary
1. Submitter:
| Company: | SRS Medical
76 Treble Cove Road, Building #3
North Billerica, MA 01862 |
|------------------|------------------------------------------------------------------------------------------------|
| Contract Person: | Lee Brody - CEO
Telephone: 978-663-2800
Fax: 425-882-1935
Email: brody@srsmedical.com |
| Date Prepared: | December 17, 2021 |
2. Device:
| Trade Name: | CT3000Pro |
|---|---|
| Common/Usual Name: | Urodynamics measurement system |
| Classification Name: | Urodynamics measurement system |
| Regulation Number: | 21 CFR 876.1620 |
| Product Codes: | FEN, EXQ |
| Regulatory Class: | Class II |
| Panel: | Gastroenterology/Urology |
3. Predicate Device:
Laborie Urodynamics System with Tetra, Product Code FEN, EXQ; cleared under K073552. The predicate device has not been subjected to a design-related recall.
4. Device Description:
The CT3000Pro system is an urodynamics testing system which combines an all-in-one touchscreen PC with the CT3000Pro console. Patient information and all data from the tests are stored on the PC's hard disk and the printer enables the user to print a hard copy report of the recorded data. It features a scale to record urine flow, as well as a pump for cystometrogram and urethral pressure profile studies.
The CT3000Pro PC software runs three types of tests: (a) catheterized urodynamics, (b) non- invasive SRS Medical
4
Image /page/4/Picture/1 description: The image contains the logo for SRS Medical. The logo is in a light blue color. The text "SRS Medical" is in a sans-serif font. Below the text is the phrase "Driven by bladder function" in a smaller font.
urodynamics, and (c) uroflow studies. A brief overview of the three test procedures is given below:
- a. For catheterized urodynamics studies, the device has up to three pressure channels which record pressure from one or two catheters (Vesical and optionally Abdominal). Perianal surface electromyography (EMG) can be recorded. The CT3000Pro also has a remote control and an electronic leak point detector for recording events.
- b. For non-invasive urodynamics studies, the device utilizes a non-invasive UroCuff to apply pressure to the urine stream to determine the pressure required to interrupt the urine flow during a voiding pressure study. Perianal and/or Abdominal surface EMG can be recorded.
- c. For uroflow studies, the device utilizes the urine scale, which is used on voiding pressure studies as well.
5. Indications for Use:
The CT3000Pro is intended for urodynamic testing. The equipment performs standard tests including uroflowmeter, cystometry, micturition, electromyography and urethral pressure profiles. The noninvasive option utilizes a penile cuff (UroCuff-Classic or UroCuff-DC) for non-invasive testing of bladder activity, by assessing the pressure necessary to interrupt urine flow.
The CT3000Pro is intended for use under the direction of a licensed physician or health care professional in an office or hospital setting.
6. Comparison of Technological Characteristics with Predicate Device:
| Characteristic | Predicate Device (Laborie Urodynamics K073552) | CT3000Pro |
|---|---|---|
| Indications for Use | Laborie Urodynamic systems are intended for | |
| Urodynamic testing. The traditional equipment | ||
| performs standard tests including uroflowmeter, | ||
| cystometry, micturition, electromyography and | ||
| urethral pressure profiles. The accessory to our | ||
| standard equipment, Tetra near infrared spectroscopy, | ||
| for non-invasive testing of bladder activity, aiding in | ||
| the diagnosis of patients with lower urinary tract | ||
| symptoms - that is patients who suffer from urinary | ||
| incontinence. | ||
| All Urodynamic equipment including the Laborie | ||
| Urodynamic system with Tetra Accessory are for use | ||
| under the direction of a licensed physician or health | ||
| care professional in an office or hospital setting. | The CT3000Pro is intended for urodynamic | |
| testing. The equipment performs standard | ||
| tests including uroflowmeter, cystometry, | ||
| micturition, electromyography and urethral | ||
| pressure profiles. The non-invasive option | ||
| utilizes a penile cuff (UroCuff-Classic or | ||
| UroCuff-DC) for non-invasive testing of | ||
| bladder activity, by assessing the pressure | ||
| necessary to interrupt urine flow. | ||
| The CT3000Pro is intended for use under | ||
| the direction of a licensed physician or | ||
| health care professional in an office or | ||
| hospital setting. | ||
| Use Environment | Office or hospital setting. | Same |
| Patient Population | Patients who suffer from Urinary Incontinence and | |
| other lower urinary tract symptoms. | Same | |
| Users | Licensed physician or health care professional | Same |
| Catheterized | ||
| Urodynamics Test | ||
| Types | Uroflometry, cystometry, micturition, | |
| electromyography, and urethral pressure profiles. | Same | |
| Catheterized | ||
| Urodynamics Test | ||
| Technique | Traditional Catheters, infusion pump, scale. | Same |
SRS Medical
5
| CT3000Pro - Traditional 510(k) | 510(k) Summary | |
|---|---|---|
| Non-invasive | ||
| Urodynamics Test | ||
| Technique | Non-invasive testing of bladder activity using Near | |
| infrared spectroscopy. | Non-invasive testing of bladder activity | |
| using penile cuff. | ||
| Uroflow Test | ||
| Technique | Urine Scale | Same |
| Surface EMG | ||
| Technique | Standard disposable EMG electrodes. One Channel | |
| to record the electrical activity of the muscles | ||
| associated with urination. | Standard disposable EMG electrodes. Two | |
| Channels to record the electrical activity of | ||
| the muscles associated with urination. | ||
| Communication | Direct connection to the PC via USB cable | Same |
| Data Storage | Local PC | Same |
| System | ||
| Components | Instrument console, personal computer, scale, pump. | Same |
| Electromechanical Characteristics | ||
| Electrical | ||
| Classification | Class I Equipment Type BE Applied Parts | Same |
| Degree of | ||
| Protection Against | ||
| Ingress of Water | IPXO Equipment | Same |
| Mode of Operation | Continuous | Same |
| Uroflow Rate | 0 - 50 ml/s | Same |
| Uroflow Volume | 0 - 1100 ml | 0 - 1500 ml |
| Pressure | -40 to 350 cmH2O | 0 to 215 cmH2O |
| EMG | -225 - 225 uV; Frequency: 2 to 800 Hz | 225 uV; Frequency: 20-500Hz |
| Pump | 5 to 140 ml/min | 0 - 100 ml/min |
| Infusion | 0 - 1000 ml | Same |
| T-Doc | -68 to 408 cmH2O | Same |
As evidenced by the above table, the subject and predicate device have different technological characteristics. Both the subject and the predicate devices are intended for urodynamic testing under the direction of a licensed physician or health care professional in an office or hospital setting. Both devices use traditional equipment to perform standard tests including uroflowmetry, micturition, electromyography and urethral pressure profiles. Both devices also perform non-invasive testing of bladder activity. Therefore, the subject and predicate device have the same intended use.
The main differences between the devices are: (a) the CT3000Pro has an optional second surface EMG channel, (b) the CT3000Pro utilizes a penile cuff for non-invasive measurements while the predicate utilized an indirect measurement technique. There are also some differences in the device hardware specifications. However, these differences do not raise different questions of safety or effectiveness and the testing mentioned below showed that the substantially equivalent with the predicate.
7. Performance Data:
Performance Data - Bench
CT3000Pro was subjected to verification and validation activities utilizing various methods and techniques to verify device performance including:
- Device Verification and Validation testing (comprehensive end-to-end t ting of functional requirements).
6
Image /page/6/Picture/0 description: The image contains the logo for RS Medical. The logo is in a light blue color. The text "RSMedical" is displayed in a sans-serif font.
- Full functional test performed on 100% of units as part of the final test during production ● release.
- Product life and durability testing. ●
Biocompatibility testing
-
- The CT3000Pro console and associated components and accessories manufactured by SRS Medical or third-party suppliers are non-contact parts, therefore, have no biocompatibility considerations.
- The CT3000Pro system requires patient-contacting components for some of the tests, such as 2. catheterized urodynamics test or non-invasive urodynamics test. Except the UroCuff-DC component all the other patient-contacting components are purchased from third party manufacturers and those components are FDA registered and used with the CT3000Pro system without modifications.
-
- Biocompatibility evaluation for the patient-contacting material of the UroCuff-DC was conducted in accordance with FDA's guidance Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process". The material met the requirements.
Electrical safety and electromagnetic compatibility (EMC)
CT3000Pro was evaluated by a third-party certified laboratory for Electromagnetic Compatibility (EMC) and Electrical Safety. The subject device met the following standards:
- · IEC 60601-1-2:2014 Medical electrical equipment Part 1-2 General requirements for safety and essential performance - Collateral standard: Electromagnetic compatibility -Requirements and tests.
- · IEC 60601-1:2005 + A1:2012 Medical electrical equipment = Part 1: General requirements for safety and essential performance
Software Verification and Validation
The CT3000Pro software was developed, validated, and documented in accordance with IEC 62304 and FDA Guidance "General Principles of Software Validation." Software verification and validation activities including code reviews, design reviews, evaluations, analyses, traceability assessment, and manual testing were performed in accordance with standards and guidance documents to demonstrate device performance and functionality. All tests met the required acceptance criteria.
Risk Management
Risk Management activities were conducted in accordance with ISO 14971 to assure that all risk related to invasive and non-invasive urodynamic testing, including use related risks and cybersecurity risks, are appropriately controlled. All control measures were verified and found to be effective. All individual and overall residual risk is acceptable. The new device has the same safety characteristics as the Predicate Device and same risk profile.
Clinical Data
Clinical performance of the non-invasive uroflow measurement technique is demonstrated through clinical data from published literature. The use of UroCuff for non-invasive urodynamic studies has been evaluated by independent research teams and published in peer-reviewed literature. There have
7
Image /page/7/Picture/1 description: The image contains the logo for SRS Medical. The logo is in a light blue color. Underneath the logo is the text "Driven by bladder function".
CT3000Pro - Traditional 510(k)
510(k) Summary
been 28 Original Research Articles published on UroCuff, as well as an additional 44 Original Research Abstracts, and 20 Technology Assessments, Clinical Guidelines and Review Articles. Specifically, a study on the use of UroCuff-Classic and UroCuff-DC using the CT3000Pro (and its predecessor CT3000Plus) supporting the safety and effectiveness was published in the Journal of Urology. This publication reports on the clinical experiences on over 50,000 UroCuff patients from 103 US hospitals and urology offices. The publication's authors practice at Mayo Clinic, Mount Sinai Hospital, and Chesapeake Urology. Each of these institutions utilizes UroCuff. From the literature data it was established that the effectiveness and safety profile of the subject device are acceptable.
8. Conclusion:
Based on the information presented in this submission, it can be concluded that the subject device is substantially equivalent to the predicate.